Effectiveness Trial of Thermal Jacket
Globally, over 15 million neonates are born preterm each year. They account for approximately 30% of global neonatal deaths and 19% of total neonatal deaths in Bangladesh. They usually die because they cannot maintain normal temperature due to their weight, immature skin and underdeveloped thermal regulatory capacity of the brain.

Maintaining continuous Kangaroo Mother Care (KMC) for at least 16-20 hours/day, is sometimes not feasible for mothers or caregivers. In addition, we also have the challenge of keeping preterm or low birthweight (LBW) neonates warm during transportation.

The scientists at icddr,b, Johns Hopkins University, and George Mason University developed the thermal jacket for keeping preterm or LBW neonate warm. We have already completed the laboratory trial on mannquins and clinical safety trial among preterm or LBW neonates. Now, we propose to build on our previous work by systematically testing the effectiveness trial of the 'thermal jacket' among preterm or LBW neonates at clinical settings.

Hypothesis: Thermal jacket can increase the rate of euthermia among the preterm or LBW neonates in the selected health facilities in Bangladesh.

Objectives: The aim of this study is to test whether the thermal jacket can attain and maintain euthermia of preterm or LBW neonates in clinical settings of Bangladesh.
- EligibilityCriteria: Inclusion Criteria:  KMC eligible neonates Heart rate 100-160 per minute Capillary Refill Time ≤ 3 sec Respiratory rate 30-59 per minute Breaths comfortable Pink in room air  Exclusion Criteria:  In nasogastric tube In oxygen therapy In intravenous fluid Sign of respiratory distress Prolonged or frequent apnea Major surgical problem Gross congenital anomaly - HealthyVolunteers: No - Gender: All - StdAgeList: Child, Adult, Older Adult